A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer
Clinical trial NCT05616494 · UNKNOWN
Trial details
- NCT number
- NCT05616494
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2024-12-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.